扁平苔藓药物治疗进展  

Advances in the drug treatment of lichen planus

作　　者：周勐[1] 简晓清[1] 庞传超[1] 

机构地区：[1]吉林大学第二医院皮肤科,长春医学硕士研究生130041

出　　处：《医学研究生学报》2013年第1期80-84,共5页Journal of Medical Postgraduates

基　　金：吉林省科技发展计划项目(200705234)

摘　　要：扁平苔藓(lichen planus,LP)是慢性或亚急性炎症性疾病,病因未明,治疗较困难。现在有多种药物用于治疗LP,除类固醇激素、维甲酸类、免疫抑制剂等常用药物外,还有柳氮磺吡啶、左旋咪唑、生物制剂等药物。文中就近年来治疗LP的药物研究进展做一综述,为正确治疗LP提供药物信息和指导。Lichen planus （LP） is a chronic or subacute inflammatory dermatosis of the mucocutaneous surfaces that can present with a variety of clinical manifestations. The pathogenesis of LP is unknown and LP is difficult to cure. A variety of drugs are used to treat LP, in addition to commonly used drugs such as steroid hormones, retinoic acid, immunosuppressant, etc. There are sulfasalazine, levamisole, biological agents and other drugs. In this paper, the latest research on the LP drug therapy are reviewed, in order to provide drug information and treatment guidance for the correct treatment of LP.

关 键 词：扁平苔藓 治疗 生物制剂 

分 类 号：R756[医药卫生—皮肤病学与性病学]